InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2024-07-19 | Josh Gottheimer(D-NJ05) | house | Purchase | $1,001 - $15,000 |
| 2024-06-18 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2023-10-16 | Josh Gottheimer(D-NJ05) | house | Purchase | $1,001 - $15,000 |
| 2023-09-15 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2021-04-14 | Josh Gottheimer(D-NJ05) | house | Purchase | $1,001 - $15,000 |
No financial data available for SGIOY.
Company may not file with SEC or CIK is unresolved.
D-Wave CEO on quantum computing's ChatGPT moment, Nvidia, & more
Shionogi’s Fetroja Contract And Data Shift U.S. Growth And Valuation Outlook
The Time to Talk about HIV is Now: ViiV Healthcare Launches "Still Here" PSA to Ignite Action Around HIV on National Youth HIV/AIDS Awareness Day
RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders
Shionogi secures $482m BARDA contract to tackle AMR crisis
Centessa is the top performing foreign healthcare stock YTD
Shionogi Receives Contract with U.S. Government Through BARDA's Project BioShield to Enhance National Preparedness for Drug-Resistant Bacterial Threats
ESCMID Global 2026: Shionogi Presents New Real-World Data Highlighting Clinical Effectiveness of Fetroja®/Fetcroja® (cefiderocol) in MBL-Producing Enterobacterales Infections
Shionogi Completes Acquisition of All Rights to RADICAVA (edaravone)
ViiV says early-stage data on VH184 for HIV could support twice-yearly dosing
Pfizer exits GSK majority-owned ViiV Healthcare; Shionogi raises stake
Roche’s Genentech launches DTC program amid Trump’s MFN directive